Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS
Inclusion in FDA’s Coronavirus Treatment Acceleration Program significantly shortens regulatory review cyclesSimultaneous patient enrollment planned in both the U.S. and […]